Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.

Autor: Mijnes J; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Tiedemann J; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Eschenbruch J; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Gasthaus J; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Bringezu S; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Bauerschlag D; Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany., Maass N; Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany., Arnold N; Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Institute of Clinical Molecular Biology, University Medical Centre Schleswig-Holstein, Campus Kiel, Christian-Albrechts-University, Kiel, Germany., Weimer J; Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany., Anzeneder T; Patients' Tumor Bank of Hope (PATH-Biobank) Foundation, München, Germany., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Rübner M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Bruno B; Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany., Heindrichs U; Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany., Freres J; Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany., Schulz H; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Hilgers RD; Institute of Medical Statistics, University Hospital RWTH Aachen, Aachen, Germany., Ortiz-Brüchle N; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., von Serenyi S; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Knüchel R; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany., Kloten V; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.; Current address: Bayer AG, Pharmaceuticals Division, Biomarker Research, Wuppertal, Germany.; Share equal senior authorship., Dahl E; Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.; RWTH centralized Biomaterial Bank (RWTH cBMB) at the Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.; Share equal senior authorship.

Publikováno v: Oncotarget [Oncotarget] 2020 Jul 28; Vol. 11 (30), pp. 2958. Date of Electronic Publication: 2020 Jul 28 (Print Publication: 2020).